Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?
Daniel Stetson, Paul Labrousse, Hugh Russell, David Shera, Chris Abbosh, Brian Dougherty, J. Carl Barrett, Darren Hodgson, James Hadfield
Topics & Concepts
MedicineDiseaseMinimal residual diseaseResidualComputational biologyInternal medicineBiologyComputer scienceAlgorithmLeukemiaCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsMolecular Biology Techniques and Applications